Today: 9 July 2026
Intel draws $150 target in AI drive, Wall Street says

Intel Shares Hold After AI Surge, Arc Chip Plays Developing

New York, May 29, 2026, 05:03 EDT

Intel shares head into Friday’s U.S. trading after a weaker finish. Investors are watching a new consumer-chip rollout as the stock’s sharp rally puts the chipmaker’s valuation on watch.

Intel shares ended Thursday at $120.89, slipping 0.72%. The stock moved between $116.31 and $123.08 during the day. It’s still trading close to its recent high of $132.75 set on May 11, market data show.

Why now: Intel is pushing to use high CPU demand to drive a bigger recovery. The challenge is if new products and its foundry tools can back a stock price that’s moved well ahead of what most expected.

Intel rolled out its Arc G-Series chips for handheld gaming PCs on Thursday. The Arc G3 and Arc G3 Extreme processors will use the same tech as Intel’s Core Ultra Series 3, which is called Panther Lake. Both chips will run on Windows 11. Intel says Acer, MSI, and OneXPlayer will start shipping devices with the new processors from June.

Intel’s vice president and GM for PC products, Dan Rogers, described the launch as “years of focused innovation” and said the chips deliver PC performance “in the palm of your hand.” The product won’t move Intel’s earnings needle alone, but it gets the company into a quicker device market where AMD has been stronger.

Acer has unveiled its Predator Atlas 8 handheld, running up to Intel’s Arc G3 Extreme processor. That makes Acer an early customer as Intel starts shipping the new chip. According to Acer, the device will also have up to Arc B390 graphics with support for ray tracing and XeSS 3 AI upscaling.

Data center demand keeps driving the stock. Reuters said in April that Intel saw strong AI-service firm orders for its CPUs in the first quarter, enough that it sold off chips it had already written down. That helped kick off a big rally in the shares. Intel CFO David Zinsner told Reuters the company had moved some “de-spec” and old products, but said, “I am not sure we have that benefit in the second quarter.” Reuters

Intel’s first-quarter report gave bulls something to work with, but the numbers weren’t all green lights. Revenue hit $13.6 billion, a 7% jump year on year. For the second quarter, Intel is guiding for revenue between $13.8 billion and $14.8 billion. Bottom line: GAAP loss per share came in at 73 cents for the quarter. On a non-GAAP basis, which takes out some line items, EPS was 29 cents. Companies often use these adjusted figures to present operating results.

Chief Executive Lip-Bu Tan said in the earnings release that AI is “moving from foundational models to inference to agentic,” and said that’s driving up demand for Intel’s CPUs and advanced packaging. Inference, he said, is when an AI system replies to a user after training.

Manufacturing has stayed in focus for analysts. Reuters cited eMarketer’s Jacob Bourne, who said CPU demand at AI data centers is giving Intel “a steadier revenue lifeline.” Ryuta Makino from Gabelli Funds, an Intel investor, told Reuters the company’s 18A chipmaking yield had to beat what the market expects. Yield means the portion of usable chips that come from a silicon wafer. Reuters

AMD was last up 4.56% at $518.09. Nvidia traded at $214.25, up 0.79%. The iShares Semiconductor ETF was at $569.47, up 1.02%. Intel’s shares last fetched $120.89, giving the company a market cap around $614.5 billion. Competition elsewhere isn’t slowing.

Chip stocks climbed. The Financial Times said Thursday that semiconductor names like Nvidia, Intel, AMD and Arm are on track for their biggest gains since the dotcom boom, driven by AI hardware demand.

The downside risk remains. Intel needs to show its foundry business can attract and keep big clients, that its 18A nodes can scale with good yields, and that AI CPU demand isn’t just a short-term spike. Earlier this month, Reuters reported Intel posted a $3.73 billion net loss less than a month ago and still faces tens of billions in spending to reach top-tier contract chipmaker status.

The stock price still acts like the comeback story is on. Investors’ patience for the next sign will get tested in Friday’s trade.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Virax Biolabs Signs Exclusive Supply Pact With Fosun Diagnostics for Southeast Asia
    July 9, 2026, 8:49 AM EDT. Virax Biolabs Group Limited (NASDAQ: VRAX) has landed an exclusive commercial supply deal with Fosun Diagnostics to cover six Southeast Asian countries: Thailand, Vietnam, Indonesia, the Philippines, Singapore, and Malaysia. The agreement is for Virax's ImmuneSelect immune profiling products, separate from its diagnostic platform that's still in the works. Virax can now supply products right away through purchase orders, eyeing near-term revenue and a wider regional presence. Fosun Diagnostics, under Fosun Pharma, will use its network for distribution across the region. The agreement leaves room for more products, higher volume, and the chance of OEM or private-label deals down the line. Pricing is set up for scale. The deal moves Virax further into the ASEAN diagnostics market.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 28.05.2026

IREN Shares Slide, Bringing Dell AI Deal and $4.4 Billion Test Into Focus
Next Story

IREN Shares Slide, Bringing Dell AI Deal and $4.4 Billion Test Into Focus

Go toTop